Rapid-Cycle Survey Collaborative for Patient and Provider Input on Immunization Issues | RFA IP 20 005

Opportunity Information: Apply for RFA IP 20 005

The Rapid-Cycle Survey Collaborative for Patient and Provider Input on Immunization Issues (Funding Opportunity Number RFA-IP-20-005) is a CDC cooperative agreement designed to create and maintain a fast, reliable way to gather timely feedback on urgent and emerging vaccination topics. The core idea is to support a standing survey capability that can quickly field multiple national surveys each year, drawing from scientifically selected, nationally representative samples of both healthcare providers and members of the public. By emphasizing sound methodology and adequate response rates, the program is meant to produce findings that can be generalized beyond the survey sample and used with confidence by public health decision-makers.

The opportunity focuses on two main populations. On the provider side, surveys should target physicians who routinely deliver or counsel on vaccinations, specifically pediatricians, family physicians, obstetrician/gynecologists, and general internists, or an appropriate combination of those groups. On the public side, surveys should cover individuals ages 18 years and older and intentionally include subpopulations that often drive or are heavily affected by immunization policy and practice decisions. Examples named in the announcement include pregnant women, parents of children ages 0 to 5, and people living with chronic medical conditions. This design reflects the need to understand not only general attitudes and behaviors, but also the perspectives of groups for whom vaccine guidance, uptake barriers, and risk-benefit considerations can be different.

The expected work has two annualized objectives throughout the project period. First, the awardee is expected to conduct multiple surveys every year of both providers and the public, using methods rigorous enough to support national inference. That implies careful sampling, questionnaire design, fielding approaches that reduce bias, and steps to secure strong participation so results are credible and usable. Second, the awardee must disseminate results broadly and in a practical form so they can be acted on, not just archived. The intended uses of the survey findings are explicitly tied to real-world immunization decisions, including helping inform recommendations for new vaccines, guiding strategies to improve vaccination coverage, and supporting contingency planning for urgent operational challenges such as vaccine supply shortages or other time-sensitive disruptions.

Administratively, this is a discretionary funding opportunity from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), using a cooperative agreement mechanism. That structure generally indicates substantial federal involvement, meaning CDC is likely to work closely with the recipient on priorities, timing, and deliverables to ensure the survey system can respond quickly to pressing immunization questions. The program is listed under CFDA 93.185 and anticipated a single award, with an award ceiling of $500,000. Eligible applicants were broad and included various levels of government, public and state-controlled institutions of higher education, tribal governments and tribal organizations, public housing authorities/Indian housing authorities, and nonprofit organizations with or without 501(c)(3) status (with additional eligibility details referenced in the full announcement). The notice was created October 29, 2019, with an original application closing date of February 25, 2020, and submissions due by 5:00 p.m. Eastern Time on the due date.

Overall, the grant is essentially about building a rapid-response, nationally representative survey engine that can capture what clinicians and the public are thinking and doing around immunization in near real time, then translating those insights into widely shared evidence that helps CDC and partners make better, faster decisions about vaccine policy, communication, and program implementation.

• The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Rapid-Cycle Survey Collaborative for Patient and Provider Input on Immunization Issues" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185.
• This funding opportunity was created on Oct 29, 2019.
• Applicants must submit their applications by Feb 25, 2020 Electronically submitted applications must be submitted no later than 500 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA IP 20 005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: